直径≥3cm作为唯一危险特征的胰腺囊性肿瘤自然史
单中心回顾性研究纳入89例诊断时囊径≥3cm且无其他危险特征的胰腺囊性肿瘤患者,中位随访85.7个月。随访期间13例出现进展或切除,无胰腺癌或高级别异型增生,累积进展发生率57个月时为13.7%。结论认为此类患者可安全监测。
要点
- 囊径≥3cm作为唯一危险特征时,监测期间进展率低。
- 本队列未发现胰腺癌或高级别异型增生。
- 此类患者可考虑安全监测而非立即手术。
核心结论
- 直径≥3cm作为唯一危险特征的胰腺囊性肿瘤监测期间进展率低,本队列无胰腺癌或高级别异型增生发生。
研究设计与样本
- 单中心回顾性综述,纳入2010至2019年诊断时囊径≥3cm且无其他危险特征的胰腺囊性肿瘤患者89例,排除假性囊肿及活检证实的恶性或非IPMN囊肿。
主要发现
- 中位年龄70.9(21至91)岁,囊径3.5(3.10至9.7)cm,随访85.7(30.8至139.3)个月。
- 随访期间13例出现囊性进展或切除,术后病理无胰腺癌或高级别异型增生。
- 自监测开始累积进展发生率:3个月3.4%(95%CI 0.9%至8.8%),9个月5.6%(95%CI 2.1%至11.9%),15个月9.0%(95%CI 4.2%至16.2%),21个月11.2%(95%CI 5.7%至18.8%),57个月13.7%(95%CI 7.5%至21.8%)。
临床怎么用
- 对于囊径≥3cm且无其他危险特征的胰腺囊性肿瘤,可考虑安全监测,无需仅因直径≥3cm而立即手术。
局限性
- 单中心回顾性设计,样本量有限,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple pancreatic cyst surveillance guidelines include cyst diameter 3 cm or greater as a worrisome feature prompting surgical referral. STUDY DESIGN: This was a single-center retrospective review of patients with pancreatic cysts 3 cm or greater at diagnosis and no other worrisome features. Cyst progression was defined as the development of additional worrisome features, pancreatic cancer diagnosis, or pancreatectomy. Pseudocysts and biopsy-proven malignancies or non-intraductal papillary mucinous neoplasm cysts at initial consultation were excluded. RESULTS: Between 2010 and 2019, 89 patients met eligibility criteria with median age of 70.9 (21 to 91) years, cyst size of 3.5 (3.10 to 9.7) cm, and follow-up of 85.7 (30.8 to 139.3) months. Cyst progression or resection occurred in 13 during follow-up There were no cases of pancreatic cancer or high-grade dysplasia on postoperative pathology. Twelve patients (13%) died without evidence of progression. Cumulative incidence of progression from surveillance initiation was 3.4% (95% CI 0.9% to 8.8%) at 3 months, 5.6% (95% CI 2.1% to 11.9%) at 9 months, 9.0% (95% CI 4.2% to 16.2%) at 15 months, 11.2% (95% CI 5.7% to 18.8%) at 21 months, and 13.7% (95% CI 7.5% to 21.8%) at 57 months. CONCLUSIONS: Pancreatic cysts with a diameter 3 cm or greater as the sole worrisome feature can be safely monitored with low rates of progression during surveillance, and no incidence of cancer or high-grade dysplasia in our cohort.
引用
- Choubey AP, Alessandris R, Armstrong MT, et al. Natural History of Pancreatic Cyst with Diameter as Solitary Risk Factor. J Am Coll Surg. 2025. PMID: 40110866. doi:10.1097/XCS.0000000000001389
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。